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Abstract
Background: Patients with infections account for a significant proportion of Emergency Department (ED)
workload, with many hospital patients admitted with severe sepsis initially investigated and resuscitated in the ED.
The aim of this registry is to systematically collect quality observational clinical and microbiological data regarding
emergency patients admitted with infection, in order to explore in detail the microbiological profile of these
patients, and to provide the foundation for a significant programme of prospective observational studies and
further clinical research.
Methods/design: ED patients admitted with infection will be identified through daily review of the computerised
database of ED admissions, and clinical information such as site of infection, physiological status in the ED, and
components of management abstracted from patients’ charts. This information will be supplemented by further
data regarding results of investigations, microbiological isolates, and length of stay (LOS) from hospital electronic
databases. Outcome measures will be hospital and intensive care unit (ICU) LOS, and mortality endpoints derived
from a national death registry.
Discussion: This database will provide substantial insights into the characteristics, microbiological profile, and
outcomes of emergency patients admitted with infections. It will become the nidus for a programme of research
into compliance with evidence-based guidelines, optimisation of empiric antimicrobial regimens, validation of
clinical decision rules and identification of outcome determinants. The detailed observational data obtained will
provide a solid baseline to inform the design of further controlled trials planned to optimise treatment and
outcomes for emergency patients admitted with infections.
Background
Emergency department and infections
Patients with infections ranging in severity from uncom-
plicated cellulitis to fulminant septic shock account for
a significant proportion of Emergency Department (ED)
workload [1]. Furthermore, studies based in the inten-
sive care unit (ICU) reveal that the majority of patients
with severe infections are admitted after first presenting
to the ED and receiving initial diagnostic workup and
treatment [2]. Given the key role of the ED in diagnosis,
risk stratification and initial treatment of patients with
infection, it is clear that ED clinicians are ideally placed
to contribute significantly to research in this area.
Collecting rigorous, quality observational data in this
setting will provide the foundation for a significant pro-
gramme of clinical research.
Potential uses and benefits of a prospective sepsis
registry
The benefits of establishing a comprehensive and detailed
prospective database on patients admitted with infection
are numerous. These data can provide a baseline mea-
surement of important cohort characteristics, spectrum
of disease severity, and outcomes for various subgroups.
By collecting data on the investigations and treatment
initiated, compliance with established best-practice
guidelines can be assessed, and changes may be quanti-
fied post implementation of quality-improvement initia-
tives. Comprehensive data on microbiological isolates
and associated sensitivities will enable the formulation of
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It is only with a large, quality database that prognostic
associations between variables and outcome can be
sought, facilitating the validation of scoring systems and
decision rules established elsewhere, and the develop-
ment of locally-derived scoring systems and decision
rules. A critical examination of the patterns and trends
in observational data may generate hypotheses and pro-
vide the basis for further experimental trials. In many
circumstances observational data provide the only evi-
dence to guide future management (e.g. time to antibio-
tics in septic shock) [2], because it would be unethical
to test certain hypotheses within a randomised trial
design. This important role of well-designed studies
using detailed, prospective, observational data in advan-
cing our knowledge and understanding of complex clini-
cal issues has recently been emphasised [3].
Methodological standards for clinical registries
A clinical register is defined as a database of systemati-
cally collected, health-related information and, together
with the system governing the register, is known as a
registry [4].
Guidelines for the structure of this type of clinical reg-
istry exist, outlining necessary characteristics such as the
collection of variables for risk adjustment, indicators to
assess quality of care, and outcome data. The “Operating
Principles and Technical Standards for Australian Clini-
cal Quality Registries” [4] exhaustively specifies further
desirable characteristics of clinical registries regarding
the mode of data collection, data elements, risk-adjust-
ment factors, data security and quality, organisation and
governance, ethics and privacy. Our database has been
designed to comply with as many of these characteristics
as is practically possible.
Review of previous studies
There are many examples of quality observational data-
bases that contribute significantly to the knowledge and
understanding of complex clinical problems and provide
frameworks from which to direct scientific enquiry.
These include the National Traumatic Coma Database
[5] and the Australian and New Zealand Intensive Care
Society Adult Patient Database [6]. Most clinical data-
bases of patients with infections include only those with
severe sepsis or septic shock [2,7] and are often multi-
centred and/or ICU-based. Databases of ED patients
with infections of all severities are less common, but
examples do exist and are represented in numerous stu-
dies that have contributed significantly to the ED
literature.
Researchers at the Beth Israel Deaconess Medical
Centre in Boston have collected rigorous prospective
data on emergency patients admitted with infection over
several discrete time periods. Using the ordering of
blood cultures by the treating emergency physician as
an indicator of suspected infection, data were collected
on a series of 3,179 patients between February 2000 and
February 2001. A number of studies have since been
published between 2003 and 2010 using this dataset,
including a paper describing the derivation of the Mor-
tality in Emergency Department Sepsis (MEDS) score
[8]. This is a severity scoring system that was subse-
quently validated at one year [9] and was the subject of
a recent complimentary review [10]. A further dataset
publication provided evidence that the Charlson Co-
morbidity score [11], a four-point score developed to
objectively quantify the burden of co-morbid illness,
also predicted one-year mortality in these patients [12].
A 2006 paper explored the prognostic implications of
organ dysfunction and the presence of the Systemic
Inflammatory Response Syndrome (SIRS) [13], and a
recent publication found a poor association between
abnormal temperature or leucocytosis and subsequently
proven bacteraemia [14].
Data on several large cohorts of emergency patients
admitted with clinical suspicion of infection were again
collected at Beth Israel Deaconess Medical Centre
between 2003 and 2006. At least seven studies have
been published using these data, advancing our knowl-
edge and understanding of emergency patients with
infections and the associated determinants of outcome.
Several severity scoring systems have been validated [15]
and the association between lactate and poor outcome
h a sb e e ne x p l o r e di nd e t a i l[ 1 6 , 1 7 ] .D o n n i n oe ta l .[ 1 8 ]
concluded co-incident treatment with “statins”
(hydroxy-methyl-glutaryl co-enzyme A inhibitors) was
associated with improved outcomes in patients admitted
with infections, and a rule comprising weighted risk fac-
tors for poor outcome in elderly patients admitted with
infection was derived and validated [19]. In recently
published studies, early abnormalities in coagulation sys-
tem parameters were independently associated with
poor outcome [20], and factors associated with clinical
deterioration and transfer to ICU after admission to a
ward were identified [21].
The productivity of the investigators at Beth Israel
Deaconess Medical Centre summarised above demon-
strates that the creation and maintenance of a large
database of detailed information on emergency patients
with the full spectrum of disease severity is achievable
and can contribute substantially to our understanding of
this complex disease process and its management. Large
observational databases should ideally be multi-centred,
national or even international in scope in order to maxi-
mise power and generalisability [4]. However, the
labour-intensive process of data abstraction from paper
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cal proposition. The inclusion of large numbers of
patients, admitted with all severities of infection, will
enhance the power of observations made and the rele-
vance of these observations to emergency medicine clin-
icians and researchers.
Objective
The objective of this paper is to describe the creation of
a comprehensive, systematic and detailed database of
the way in which patients with infections present and
are treated at a typical inner city university hospital ED.
Data regarding microbiological isolates and their asso-
ciated sensitivities will enable the optimisation of
empirical guidelines for antimicrobial therapy. Together
with accurate outcome data, it will be possible to assess
compliance with established guidelines and best practice,
validate scoring systems, investigate factors of prognostic
significance, and provide solid baseline data to inform
further studies and quality improvement initiatives.
Methods/Design
Setting and study population
This study will be conducted in the ED of an adult inner
city university hospital in Australia with an annual cen-
sus of over 72,000. Patients eligible for inclusion will be
those presenting to the ED and subsequently admitted
to hospital with a primary diagnosis indicating clinical
suspicion of infection. Those patients transferred from
another hospital or under the age of 18 years will be
excluded.
Data collection process
On a daily basis, trained data abstractors will scrutinise
the hospital electronic database record of emergency
patients admitted over the 24-hour period to midnight
the night before. Those patients with an admission diag-
nosis indicating or suggestive of infection according to
International Classification of Diseases version 10 coding
will be listed (see additional file 1), and the charts of the
patients thus identified will be examined to assess suit-
ability for study inclusion. Only those patients that are
judged to have infection as the most likely cause for
their admission according to both the treating ED senior
medical officer and the admitting team will be enrolled.
Data will be abstracted from the charts of enrolled
patients, with information recorded on case report
forms and subsequently entered into a secure compu-
terised study database (Access, Microsoft, Redmond,
WA). We have shown with pilot data that with appro-
priate training, our data abstractors achieve a high
degree of inter-rater agreement (97%). At a later date
this clinical information will be supplemented by further
information from other hospital electronic databases,
regarding pathology and microbiology results and hospi-
tal length of stay (LOS). Mortality outcome data will be
obtained from periodic interrogation of the Australian
Institute of Health and Welfare National death index
[22]. This registry records vital status data for all indivi-
duals deceased within Australia.
Variables recorded
Table 1 lists the variables recorded in the database.
Clinical details such as site of infection, physiological
status and treatment in ED and co-morbid conditions
will be abstracted directly from the hospital paper chart.
Values recorded for physiological status will be the most
abnormal values recorded in the ED, and missing phy-
siological values will be recorded as such and assumed
to be in the normal range for analysis purposes. Results
of laboratory tests and microbiological assays will be
transferred manually from hospital electronic databases.
Microbiological isolates cultured from samples taken
in the ED and up to 48 hours after presentation will be
deemed potentially relevant causative organisms.
A more liberal approach will be taken regarding results
from other tests such as serology, antigen tests and
nucleic acid amplification assays. Cases in which clinical
interpretation is required in order to clarify issues such
as site of infection and relevance of microbiological iso-
lates will be referred to a panel comprising an Emer-
gency Physician, Intensivist, and Infectious Disease
Physician/Microbiologist for adjudication.
Derived variables
A number of derived variables or scores will also be
recorded in the database. The Mortality in Emergency
Department Sepsis (MEDS) score sums nine weighted
components: (age > 65 years, terminal illness, tachyp-
noea/hypoxia, shock, thrombocytopaenia, bands >5%,
altered mental status, nursing home residence, and
lower respiratory tract infection) and has been validated
as an accurate mortality-risk stratification tool in ED
patients with infection [15,23]. Our laboratory does not
routinely measure leukocyte bands, so effectively a mod-
ified MEDS score comprising the remaining eight com-
ponents will be recorded.
The Simplified Acute Physiology Score [24] was ori-
ginally developed as a predictive tool in intensive care
patients and has subsequently been shown to have uti-
lity in ED patients [25,26]. This score is a function of 17
weighted clinical variables and estimates the probability
of hospital mortality. The Charlson Co-morbidity score
is a frequently-used index of co-morbid illness burden,
which has been validated in a similar cohort of emer-
gency patients with infection [12]. The calculation of
these three scores will enable score validation in our
cohort, allow comparison of our patients with those in
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ness and burden of co-morbidity in regression analyses.
Indices of Organ Dysfunction
A modified SOFA score [27] will be used to indicate
and quantify organ dysfunction across six organ systems
(see table 2). The SOFA score is a validated and widely
used tool for quantifying organ dysfunction in patients
w i t hi n f e c t i o n ,a n di sap r e f e r r e dm e t h o dl i s t e db yt h e
Surviving Sepsis Campaign consensus guidelines [28].
Several modifications to the score as originally published
have been made for the purposes of this study. The
published SOFA cardiovascular system (CVS) score
incorporates the potential use of a variety of vasopressor
and inotropic agents, including noradrenaline, adrena-
line, dopamine and dobutamine. The modified SOFA
cardiovascular system score reflects local practice of
using noradrenaline almost exclusively as the vasopres-
sor of choice in patients with septic shock. Adrenaline
will be considered equivalent to noradrenaline for the
Table 1 Variables recorded in the database
Data type Variables recorded
Demographics Age, gender, postcode
Site of infection Classified: respiratory, urinary tract, abdominal/pelvic, soft tissue, skeletal, neurological, vascular, unknown source.
Aetiological agents
identified
Results of positive cultures, serology, antigen tests, nucleic acid amplification.
Physiological status
in ED
SIRS criteria, initial and lowest systolic blood pressure, oliguria (urine output less than 0.5 ml/kg/hour for 2 consecutive
hours), oximetry values.
Pathology tests in ED Results of biochemistry and haematology profiles. Further data may also be available such as results of blood gas analyses
and coagulation profiles.
Treatment in ED Amount and type of fluid administered
Type and timing of antimicrobial therapy
Other variables Limitations on therapy (e.g. not for ICU admission)
Nursing home status
Antibiotics prior to admission
Hospital admission in the past month
Severity of illness MEDS score
SAPS II score
Co-morbid illness Charlson Co-morbidity score
Organ dysfunction Modified SOFA score
Outcomes Hospital length of stay
ICU length of stay (where applicable)
Date of death (where applicable)
MEDS = Mortality in Emergency Department Sepsis; SAPS II = New Simplified Acute Physiology Score; SOFA = Sequential Organ Function Assessment.
Table 2 modified SOFA score
Modified SOFA score
Organ
system
Determinants 0 1 2 3 4
RESP PaO2/FiO2 +
SaO2%
>400
>94% (RA)
<400
90-94%
<300
<90% (RA)
<200 <100
CVS Blood pressure, +
Vasopressor
requirement
SBP > 90 at all
times
SBP > 90 only
after
fluid bolus 20-30
ml/kg
SBP < 90 despite fluid
bolus.
NA < 8 (mcg/min)
NA 8-15 (mcg/min) NA > 15 (mcg/min)
HAEM Platelet count (x10
9/l) >150 <150 <100 <50 <20
GIT Bilirubin (micromol/l) <20 20-32 33-101 102-204 >204
CNS Glasgow Coma Scale
(GCS) score
15 13-14 10-12 6-9 3-5
RENAL Creatinine (micromol/l) +
Urine output (ml/kg/hour)
<120 >120 Or UO <0.5
for 2 hours
>170 >300 >440
RESP = respiratory system; CVS = cardiovascular system; HAEM = haematological system; GIT = gastro-intestinal system; CNS = central nervous system; RENAL =
renal system;
PaO2 = arterial partial pressure of oxygen (mmHg); FiO2 = fractional inspired oxygen; RA = room air; SBP = systolic blood pressure (mmHg); NA = noradrenaline;
GCS = Glasgow Coma Scale; UO = urine output.
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and vasopressor infusion must be required for at least
one hour.
Our respiratory system score utilises the ratio of arter-
ial partial pressure of oxygen to fractional inspired oxy-
gen (PaO2/FiO2) as originally published, with the
addition of pulse oximetry saturation (SpO2) >94% on
room air indicating no respiratory dysfunction, and
SpO2<90% on room air indicating a respiratory SOFA
score of two. These additions were made to reflect the
fact that many ED patients will not have an arterial
blood gases analysis performed, but SpO2 readings will
be obtained in almost all patients.
Lastly, creatinine concentration cut-offs have been
slightly adjusted at the lower scores to reflect the local
laboratory reference range, and oliguria (defined as urine
output less than 0.5 ml/kg/hour for two consecutive
hours) scoring two points has replaced an impractical ser-
ies of daily urine balances as detailed in the original SOFA
score. The other organ system SOFA scores (haematology,
central nervous system, and gastrointestinal) remain
unchanged from the original SOFA score gradings.
The proposed dataset includes a comprehensive descrip-
tion of all relevant characteristics of patients with infec-
tions that are routinely measured at the time of ED
assessment. The recording of SIRS criteria and SOFA
scores enables stratification of database patients into the
categories of sepsis, severe sepsis and septic shock as
defined by the Surviving Sepsis Campaign consensus
guidelines [28]. The collection of sufficient data to calcu-
late MEDS and SAPS II scores for each patient will facili-
tate validation of these scores, and comparison of patients
in studies using this database with other patient cohorts.
Data integrity
A number of strategies will be introduced to ensure the
quality of the data entered in the registry:
1. All individuals collecting the data for the registry
will be trained in data collection and data entry
methods.
2. The database incorporates validation fields which
provide warnings if a data value falls outside the
expected range.
3. The database will be checked on a monthly basis
for completeness. A report of missing data will be
printed and provided to the data collection team for
follow-up.
4. A data audit will be conducted every six months.
Within this audit, the following data checks will be
conducted:
a. Every field will be checked for values outside
the standard reference range. Extreme values will
be investigated for accuracy.
b. All data will be rechecked against original
paper-based data.
Data security
The registry is a Microsoft Access document that is
stored on a protected network drive, which is accessible
only to authorised users. Individuals with access to the
network drive must enter a second password to allow
them entry to the database. There are two levels of
access to the database.
1) User access. This access is available to data collec-
tors and only allows data entry.
2) Super-user access. This access enables users to
view and modify all sections of the database.
The database contains a separate file that links the
patient’s study ID number to their hospital identification
number, which will enable re-identification of the data if
necessary. This file is accessible only to super-users and
requires a separate password to be opened.
Ethics approval
The collection of this data as described above has been
approved by the Royal Brisbane and Women’sH o s p i t a l
Human Research Ethics Committee (HREC). A waiver
for informed consent was obtained owing to the entirely
observational nature of the project. Ethics approval will
be sought for further studies conducted using the
database.
Limitations
Our reliance on the diagnosis field of the ED admis-
sions database to identify potential study candidates
m a yr e s u l ti ns o m ee l i g i b l ep a t i e n t sa d m i t t e dw i t h
infection being missed. It is possible to enter in the
ED diagnosis field a major symptom such as abdominal
pain or headache, rather than an established diagnosis.
During data collection, an attempt will be made to list
and peruse the charts of not only those patients with
clear diagnoses indicating infection, but also those
admitted with symptoms that may be suggestive of
infection.
It is also possible that patients may be included but
ultimately discharged with a diagnosis other than infec-
tion. Inadvertent inclusions will be minimised by enrol-
ling only those patients with both ED and admitting
team diagnosis indicating infection.
The acquisition of data from patients’ charts has the
potential to result in incomplete or incorrect data, espe-
cially regarding relevant co-morbid conditions. However
the abstraction of data with access to patients’ full hos-
pital records as planned will minimise this effect.
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Page 5 of 7Discussion
This database will provide substantial insights into the
characteristics, microbiological profile, and outcomes of
emergency patients admitted with infections. It will pro-
vide the substrate for a programme of research into
compliance with evidence-based guidelines, the valida-
tion of clinical decision rules and the identification of
outcome determinants.
The detailed observational data obtained will provide
solid baseline data with which to modify empiric antimi-
crobial regimes and to inform the design of further con-
trolled trials planned to optimise treatment and
outcomes for emergency patients admitted with
infections.
Additional material
Additional file 1: ED admission ICD-10 codes potentially indicating
infection.
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